Amylyx Pharmaceuticals Inc's total assets for Q2 2025 were $194.60M, a decrease of -11.42% from the previous quarter. AMLX total liabilities were $26.72M for the fiscal quarter, a 46.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.